XML 19 R10.htm IDEA: XBRL DOCUMENT v3.22.2.2
REVENUE
 6 Months Ended
Jun. 30, 2022
Revenue from Contract with Customer [Abstract]  
REVENUE REVENUE

Revenues are derived primarily from the sale of dental equipment and dental and healthcare consumable products. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods or providing services.



Net sales disaggregated by product category for the three and six months ended June 30, 2022 and 2021 were as follows:
Three Months Ended Six Months Ended
(in millions) 2022 2021 2022 2021
Equipment & Instruments $ 169  $ 176  $ 335  $ 347 
CAD/CAM 129  127  235  256 
Orthodontics 76  81  144  149 
Implants 149  158  304  311 
Healthcare 72  75  142  149 
Technology & Equipment segment net sales $ 595  $ 617  $ 1,160  $ 1,212 
Endodontic & Restorative $ 312  $ 328  $ 605  $ 640 
Other Consumables 116  117  227  236 
Consumables segment sales $ 428  $ 445  $ 832  $ 876 
Total net sales $ 1,023  $ 1,062  $ 1,992  $ 2,088 


Net sales disaggregated by geographic region for the three and six months ended June 30, 2022 and 2021 were as follows:
Three Months Ended Six Months Ended
(in millions) 2022 2021 2022 2021
United States $ 358  $ 363  $ 666  $ 710 
Europe 414  429  825  846 
Rest of World 251  270  501  532 
Total net sales $ 1,023  $ 1,062  $ 1,992  $ 2,088 

Contract Assets and Liabilities


The Company normally does not have contract assets in the course of its business. Contract liabilities, which represent billings in excess of revenue recognized, are primarily related to advanced billings for customer aligner treatment where the performance obligation has not yet been fulfilled. The Company had $72 million and $68 million of deferred revenue recorded in Accrued liabilities in the Consolidated Balance Sheets at June 30, 2022 and December 31, 2021, respectively. Prior year deferred revenue of approximately $42 million was recognized in the current year. The Company expects to recognize significantly all of the remaining deferred revenue within the next twelve months.


Allowance for Doubtful Accounts



Accounts and notes receivables-trade, net are stated net of allowances for doubtful accounts and trade discounts, which were $12 million at June 30, 2022 and $13 million at December 31, 2021. For the three months and six months ended June 30, 2022 and 2021, changes to the provision for doubtful accounts including write-offs of accounts receivable that were previously reserved were insignificant. Changes to this provision are included in Selling, general, and administrative expenses in the Consolidated Statements of Operations.